FA
MIRM icon

Faithward Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

Faithward Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.28M Buy
28,035
+568
+2% +$57K 0.4% 71
2026
Q1 		$2.54M Buy
27,467
+126
+0.5% +$11.9K 0.36% 78
2025
Q4 		$2.16M Buy
+27,341
New +$1.96M 0.32% 80

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Faithward Advisors's MIRM Position: Q2 2026 in Review

Faithward Advisors increased its Mirum Pharmaceuticals (MIRM) stake by 2.1% in Q2 2026, buying an estimated $57K and bringing the position to 28,035 shares worth $3.28M. The position accounts for 0.4% of the portfolio, ranked #71.

Faithward Advisors first reported a position in MIRM in Q4 2025 and has held it in 3 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Faithward Advisors held 28,035 shares of Mirum Pharmaceuticals worth $3.28M as of Q2 2026.
  • Faithward Advisors bought 568 Mirum Pharmaceuticals shares in Q2 2026, an estimated $57K.
  • Mirum Pharmaceuticals made up 0.4% of Faithward Advisors's portfolio in Q2 2026, its #71 holding.
  • Faithward Advisors first reported a position in Mirum Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.